PharmAlliance Announces Acquisition of Monitor for Hire
With this acquisition, PharmAlliance expands its global reach to serve the development and commercialization needs across the drug, biologic, and device development lifecycle by providing diverse and disruptive end-to-end solutions.
- With this acquisition, PharmAlliance expands its global reach to serve the development and commercialization needs across the drug, biologic, and device development lifecycle by providing diverse and disruptive end-to-end solutions.
- View the full release here: https://www.businesswire.com/news/home/20240111783978/en/
The Monitorforhire acquisition is the second for PharmAlliance, a portfolio company of Waud Capital . - In September 2023, PharmAlliance acquired BioBridges , which provides clinical development services to emerging and established pharmaceutical, biotechnology, and medical device companies.
- “Monitorforhire’s unique approach to providing essential clinical research monitoring resources is a valuable extension of the PharmAlliance portfolio,” said Mark Bouck, Chairman & CEO of PharmAlliance and BioBridges.